Academic yr: <<< Previous
2018
2019
2020
|
2021
|
2022
Next >>>
Department of Pharmacology
|
■ Summary
|
■ Research grants & projects
|
1.
|
Budget amount：\3,200,000 (代表)
|
|
2.
|
Budget amount：\1,000,000 (代表)
|
|
3.
|
Budget amount：\4,960,000 (代表)
|
|
4.
|
Budget amount：\2,000,000 (代表)
|
|
5.
|
Project title：Involvement of neuronal guidance in premetastatic niche formation
Budget amount：\5,000,000 (代表)
|
|
6.
|
Budget amount：\500,000 (代表)
|
|
7.
|
Budget amount：\2,000,000 (代表)
|
|
8.
|
Budget amount：\1,818,182 (代表)
|
|
Display 5 items
|
|
Display all(8)
|
|
To the top
|
|
■ Research works
| Journal |
Book |
Presentation |
Other presentations |
| Japanese | English |
Japanese | English |
Domestic | international |
| First author | Corresponding
Author | Co-author | First author | Corresponding
Author | Co-author |
First author | Co-author | First author | Co-author |
Presenter | Co-presenter | Presenter | Co-presenter |
Presenter | Co-presenter |
| 2 | 2 | 0 | 2 | 2 | 1 |
0 | 1 | 0 | 0 |
0 | 0 |
0 | 0 |
0 | 0 |
|
|
To the top
|
|
■ Published papers
|
Original article
|
|
1.
|
Kaji Kenjiro, Maeda Shingo, Yonezawa Tomohiro, Kaji Noriyuki, Hori Masatoshi：
Protease-activated receptor-2 is associated with adverse outcomes in canine mammary carcinoma.
Veterinary Pathology
：58(1):53-58(1):62
, 2020.10
DOI:10.1177/0300985820963087
|
|
Review article
|
|
1.
|
塚原富士子†, 丸義朗：
特集 COVID-19 薬剤開発・薬物治療.
東京女子医科大学雑誌
91
(1)
：19-28
, 2021.2
DOI:https://doi.org/10.24488/jtwmu.91.1_19
|
|
2.
|
塚原富士子†, 丸義朗：
総説 炎症性疾患 （6）炎症とがん.
東京女子医科大学雑誌
90
(6)
：119-125
, 2020.12
DOI:https://doi.org/10.24488/jtwmu.90.6_119
|
|
3.
|
Maru Yoshiro：
Premetastasis.
Cold Spring Harbor perspectives in medicine
：a036897
, 2020.11
DOI:10.1101/cshperspect.a036897
|
|
4.
|
Maru Yoshiro, Katsuaki Ieguchi†：
Eph/Ephrin Signaling in the Tumor Microenvironment.
Advances in experimental medicine and biology
1270
：45-56
, 2020.10
DOI:10.1007/978-3-030-47189-7_3.
|
|
To the top
|
|
■ Books
|
1.
|
塚原富士子, 丸義朗：
抗腫瘍薬.
エース薬理学
263-291.
南山堂,
東京,
2020.8
|
|
To the top
|
|
